256 related articles for article (PubMed ID: 21558919)
21. Squamous cell carcinoma of the oral tongue: a 25-year, single institution experience.
Mosleh-Shirazi MS; Mohammadianpanah M; Mosleh-Shirazi MA
J Laryngol Otol; 2009 Jan; 123(1):114-20. PubMed ID: 18588737
[TBL] [Abstract][Full Text] [Related]
22. [Multivariate analysis for prognostic predictors in the cN0 squamous cell carcinoma of the tongue].
Zhao H; Zeng ZY; Chen FJ; Xu GP; Wu GH; Guo ZM; Zhang Q
Ai Zheng; 2003 Feb; 22(2):206-9. PubMed ID: 12600302
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade.
Kademani D; Bell RB; Bagheri S; Holmgren E; Dierks E; Potter B; Homer L
J Oral Maxillofac Surg; 2005 Nov; 63(11):1599-605. PubMed ID: 16243176
[TBL] [Abstract][Full Text] [Related]
25. Oral tongue cancer in young patients: a matched analysis.
Garavello W; Spreafico R; Gaini RM
Oral Oncol; 2007 Oct; 43(9):894-7. PubMed ID: 17307026
[TBL] [Abstract][Full Text] [Related]
26. Tongue cancer: Is there a difference in survival compared with other subsites in the oral cavity?
Bell RB; Kademani D; Homer L; Dierks EJ; Potter BE
J Oral Maxillofac Surg; 2007 Feb; 65(2):229-36. PubMed ID: 17236926
[TBL] [Abstract][Full Text] [Related]
27. Management of contralateral N0 neck in oral cavity squamous cell carcinoma.
Koo BS; Lim YC; Lee JS; Choi EC
Head Neck; 2006 Oct; 28(10):896-901. PubMed ID: 16721743
[TBL] [Abstract][Full Text] [Related]
28. Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation.
Lim YC; Lee JS; Koo BS; Kim SH; Kim YH; Choi EC
Laryngoscope; 2006 Mar; 116(3):461-5. PubMed ID: 16540910
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological presentation of tongue cancers and early cancer treatment.
Najeeb T
J Coll Physicians Surg Pak; 2006 Mar; 16(3):179-82. PubMed ID: 16542596
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
31. Squamous cell carcinomas arising from different types of oral epithelia differ in their tumor and patient characteristics and survival.
Rautava J; Luukkaa M; Heikinheimo K; Alin J; Grenman R; Happonen RP
Oral Oncol; 2007 Oct; 43(9):911-9. PubMed ID: 17257885
[TBL] [Abstract][Full Text] [Related]
32. Primary tumor site as a predictor of treatment outcome for definitive radiotherapy of advanced-stage oral cavity cancers.
Lin CY; Wang HM; Kang CJ; Lee LY; Huang SF; Fan KH; Chen EY; Chen IH; Liao CT; Chang JT
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1011-9. PubMed ID: 20434273
[TBL] [Abstract][Full Text] [Related]
33. The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ
J Urol; 2008 Nov; 180(5):2019-23. PubMed ID: 18801542
[TBL] [Abstract][Full Text] [Related]
34. [Oral squamous sell carcinoma in North-Eastern Hungary I. Epidemiology].
Nemes J; Redl P; Boda R; Márton I
Fogorv Sz; 2006 Aug; 99(4):161-7. PubMed ID: 17016924
[TBL] [Abstract][Full Text] [Related]
35. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
36. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when?
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
Cancer; 2008 Jan; 112(1):94-103. PubMed ID: 18022917
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
38. [Mouth floor and mobile tongue epidermoid carcinomas thickness: prognostic value].
El-Okeily M; El-Bouihi M; Ricard AS; Lefebvre-Majoufre C; Deminière C; Siberchicot F; Zwetyenga N
Rev Stomatol Chir Maxillofac; 2008 Apr; 109(2):81-5. PubMed ID: 18328517
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and relative risk for survival in N1-3 oral squamous cell carcinoma: a multivariate analysis using Cox's hazard model.
Noguchi M; Kido Y; Kubota H; Kinjo H; Kohama G
Br J Oral Maxillofac Surg; 1999 Dec; 37(6):433-7. PubMed ID: 10687900
[TBL] [Abstract][Full Text] [Related]
40. Demographic, aetiological and survival differences of oral squamous cell carcinoma in the young and the old in Sri Lanka.
Siriwardena BS; Tilakaratne A; Amaratunga EA; Tilakaratne WM
Oral Oncol; 2006 Sep; 42(8):831-6. PubMed ID: 16527511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
